Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
This method reinforces saving habits by design, turning budgeting into a daily routine and reinforcing consistent contributions to savings.
28,655 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Investors eye SpaceX's potential IPO as the space economy broadens; public peers already provide exposure across laun...
As Salesforce charts its path to 2027 earnings, investors weigh growth against profitability. This guide breaks down ...
Tariff news rattled markets, but crypto found footing and moved higher. This piece breaks down the rebound dynamics, ...
Oil markets have paused, but the Exxon Chevron warning that prices may spike again in the near term has investors wat...
Goodyear reports a strong Q4 with $105 million in profit, while an investor increases exposure to $15 million. This p...
When markets wobble, the strength of a company’s balance sheet and its cash runway often beat a glossy business story...
Spotting a strong real estate market isn’t guesswork. By watching a few proven metrics that matter: spot—rent growth,...
Investing headlines love bold predictions, but long-term numbers rarely align with hype. This guide uses SpaceX as a ...
As Home Depot gears up to report, investors weigh EPS targets, margin dynamics, and housing trends. This guide breaks...
Is Rivian a millionaire-maker stock or a high-risk punt? This guide dives into the catalysts, margins, and scenarios ...
A clear, reader-friendly breakdown of Acadia’s Q4 2025 earnings. We unpack revenue trends, pipeline progress, and key...